Profils actuels chez LFB BIOMEDICAMENTS

Offres d'emploi chez LFB BIOMEDICAMENTS

Documents LFB BIOMEDICAMENTS

• LFB BIOMEDICAMENTS Obtains Marketing Authorization. for BETAFACT® 100 IU/ml. This new human coagulation factor IX concentration will cut injection volume in half versus the. current form and thus make the life of patients with hemophil
  http://www.lfb.fr/Upload/News/Fichier5/700.pdf
• LFB BIOMEDICAMENTS today announced the launch of Willfact® in Germany, a new product for ... LFB BIOMEDICAMENTS is part of LFB, a biopharmaceutical group that develops, manufactures and. markets medicinal pr
  http://hugin.info/134557/R/1401308/356396.pdf
• With 2006 sales of 268 million euros, LFB is the third largest pharmaceutical company supplying drugs to hospitals in France. ... LFB Biomédicaments is an LFB subsidiary which specializes in biological drugs; it pr
  http://www.mabgene.com/uk/press_release_LFB_MAbgene.doc
• LFB Biomédicaments obtained marketing authorisation from AFSSAPS for CLAIRYG® in December ... LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the. treatment of serious and
  http://www.lfb.fr/Upload/News/Fichier5/738.pdf
• LFB Biomédicaments est la filiale du groupe LFB spécialisée dans la fabrication et la ... chimie classique, les médicaments issus du LFB étant préparés à partir du plasma " ...
  http://www.g5.asso.fr/doc/Le_LFB_pour_les_biomedicaments.pdf
• announced that LFB BIOMEDICAMENTS (LFB) has received a positive review of Willfact ... LFB BIOMEDICAMENTS is part of LFB, a biopharmaceutical group that develops, manufactures ...
  http://hugin.info/134557/R/1474026/410433.pdf